Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Pulmonx Community
NasdaqGS:LUNG Community
1
Narratives
written by author
1
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Pulmonx
Popular
Undervalued
Overvalued
Community Investing Ideas
Pulmonx
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
LungTrax And Global Expansion Will Broaden Market Access
Key Takeaways Expansion into new markets and innovative tools like LungTrax could grow patient volume, boosting revenue and operational efficiency. Global growth in Europe, China, and potential in Japan supports geographical diversification and long-term revenue opportunities.
View narrative
US$12.36
FV
72.2% undervalued
intrinsic discount
17.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
LUNG
LUNG
Pulmonx
Your Fair Value
US$
Current Price
US$3.44
70.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-59m
251m
2015
2018
2021
2024
2025
2027
2030
Revenue US$251.1m
Earnings US$36.6m
Advanced
Set Fair Value